Collegium Pharmaceutical (COLL) Times Interest Earned (2014 - 2026)

Collegium Pharmaceutical's Times Interest Earned history runs 13 years deep, the most recent figure standing at $0.34 for Q1 2026.

• On a quarterly basis, Times Interest Earned rose 42.46% year-over-year to $0.34 in Q1 2026; TTM through Mar 2026 was $2.07, a 32.89% increase from a year earlier, with the FY2025 full-year figure at $1.62, down 29.44% from the prior year.
• Times Interest Earned slipped to $0.34 in Q1 2026 per COLL's latest filing, from $3.15 in the prior quarter.
• Across five years, Times Interest Earned topped out at $3.2 in Q4 2023 and bottomed at -$0.12 in Q1 2022.
• The 5-year median for Times Interest Earned is $0.68 (2025), against an average of $1.28.
• Across the five-year window, Times Interest Earned slumped 103.19% in 2022 and jumped 1118.05% in 2023, its largest moves.
• Year by year, Times Interest Earned stood at $0.57 in 2022, then jumped by 459.91% to $3.2 in 2023, then tumbled by 47.42% to $1.68 in 2024, then soared by 87.2% to $3.15 in 2025, then tumbled by 89.23% to $0.34 in 2026.
• Per Business Quant, the three latest COLL Times Interest Earned figures stand at $0.34 (Q1 2026), $3.15 (Q4 2025), and $0.68 (Q3 2025).